Acid Reflux Medications and Low Stomach Acid in Thyroid Patients

Acid Reflux Medications and Low Stomach Acid in Thyroid Patients

Acid reflux, a common gastrointestinal issue, affects millions worldwide. Among those, thyroid patients constitute a significant portion. An intriguing relationship exists between acid reflux medications and low stomach acid in thyroid patients, raising concerns about treatment efficacy and potential exacerbation of underlying conditions. This article explores this intricate connection, shedding light on the impact of acid reflux medications on thyroid health.

Understanding Acid Reflux and Thyroid Disorders (Read more here)

Acid reflux, clinically known as gastroesophageal reflux disease (GERD), occurs when stomach acid flows back into the esophagus, causing discomfort and potential complications such as esophagitis and Barrett's esophagus. Thyroid disorders, including hypothyroidism and hyperthyroidism, can influence gastrointestinal function, contributing to acid reflux symptoms.

The Role of Stomach Acid in Thyroid Health

Stomach acid plays a crucial role in digestion and nutrient absorption. Additionally, it aids in the activation of pepsin, an enzyme necessary for protein digestion. In thyroid patients, low stomach acid levels can hinder the breakdown of food and compromise nutrient absorption, potentially exacerbating symptoms associated with thyroid dysfunction.

Common Acid Reflux Medications and Their Mechanisms

Proton pump inhibitors (PPIs) and H2 receptor antagonists (H2 blockers) are among the most prescribed medications for acid reflux. PPIs, such as omeprazole and esomeprazole, reduce stomach acid production by inhibiting proton pumps in the stomach lining. H2 blockers, including ranitidine and famotidine, work by blocking histamine receptors, thereby decreasing acid secretion.

The Paradox of Acid Reflux Medications in Thyroid Patients

While acid reflux medications alleviate symptoms in many individuals, their long-term use may exacerbate low stomach acid levels, particularly in thyroid patients. Studies suggest that prolonged PPI use can lead to hypochlorhydria, a condition characterized by abnormally low stomach acid levels. In thyroid patients already prone to digestive issues, this can further impair nutrient absorption and exacerbate symptoms.

Clinical Evidence and Expert Opinions

Research examining the relationship between acid reflux medications and low stomach acid in thyroid patients is limited but emerging. A study published in the *Journal of Clinical Endocrinology & Metabolism* found that hypothyroid patients treated with levothyroxine and PPIs exhibited lower stomach acid levels compared to controls. Additionally, Dr. Datis Kharrazian, a renowned functional medicine practitioner, highlights the detrimental effects of acid reflux medications on thyroid function in his book "Why Do I Still Have Thyroid Symptoms?"

Navigating Treatment Options

Given the potential risks associated with acid reflux medications, particularly in thyroid patients, healthcare providers must approach treatment with caution. Alternative strategies, such as dietary modifications, lifestyle changes, and supplement interventions, may offer relief without compromising stomach acid levels. Furthermore, addressing underlying thyroid dysfunction through optimized thyroid hormone replacement therapy is essential in managing both acid reflux and associated symptoms.


The relationship between acid reflux medications and low stomach acid in thyroid patients underscores the importance of personalized healthcare approaches. While these medications provide symptomatic relief, their long-term use may exacerbate underlying conditions, including thyroid dysfunction. Healthcare providers should carefully evaluate the risks and benefits of acid reflux treatments, considering individual patient factors, testing for hypochlorhydria, and exploring alternative strategies to optimize digestive health and thyroid function.



1. Sotiropoulos A, Goulis DG, Tsiambas E, et al. Proton Pump Inhibitor Use Is Associated With Lower Gastric Acid Secretion and Serum Vitamin B12 Levels in Patients With Hypothyroidism. *Journal of Clinical Endocrinology & Metabolism*. 2020;105(11):e3998-e4003.

2. Kharrazian D. *Why Do I Still Have Thyroid Symptoms? When My Lab Tests Are Normal*: A Revolutionary Breakthrough in Understanding Hashimoto's Disease and Hypothyroidism. Morgan James Publishing; 2010.

3. Sullivan T. The Impact of Thyroid Disease on Gastrointestinal Function. *Thyroid Disorders & Therapy*. 2018;7(2):1-5.

4. Festi D, Scaioli E, Baldi F, et al. Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. *World Journal of Gastroenterology*. 2009;15(14):1690-1701.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.